We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Approval Can't Nix Allergan Patent Obviousness: Sandoz

Law360, Washington (November 5, 2012, 3:30 PM EST) -- Generic-drug maker Sandoz Inc. urged a Federal Circuit panel on Monday to lift an injunction banning it from marketing a generic version of Allergan Inc.'s glaucoma medication Combigan, saying the lower...
To view the full article, register now.